Title:
【発明の名称】RAFキナーゼ阻害剤としてのω-カルボキシアリール置換ジフェニル尿素
Document Type and Number:
Japanese Patent JP2003526613
Kind Code:
A
Abstract:
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Inventors:
Dryle, burned
Dumas, Jack
Keel, Uday
Rowinger, Timothy Bee
William Jay, Scott
Smith, roger a
Wood, Jill Yee
Monahan, Mary Catherine
Natello, Reina
Renick, Joel
Sylbury, Robert N
Dumas, Jack
Keel, Uday
Rowinger, Timothy Bee
William Jay, Scott
Smith, roger a
Wood, Jill Yee
Monahan, Mary Catherine
Natello, Reina
Renick, Joel
Sylbury, Robert N
Application Number:
JP2000593580A
Publication Date:
September 09, 2003
Filing Date:
January 12, 2000
Export Citation:
Assignee:
Bayer Corporation
International Classes:
C07C275/28; A61K31/17; A61K31/18; A61K31/24; A61K31/33; A61K31/341; A61K31/40; A61K31/4035; A61K31/44; A61K31/4406; A61K31/4409; A61K31/4439; A61K31/4453; A61K31/495; A61K31/496; A61K31/535; A61K31/5355; A61K31/5375; A61K31/5377; A61K31/54; A61P35/00; A61P43/00; C07C275/20; C07C275/22; C07C275/24; C07C275/30; C07C275/32; C07C275/36; C07C275/40; C07C291/12; C07C311/29; C07C317/22; C07D207/09; C07D209/46; C07D209/48; C07D211/72; C07D211/78; C07D213/74; C07D213/75; C07D213/79; C07D213/81; C07D213/82; C07D295/12; C07D295/13; C07D295/135; C07D295/18; C07D295/192; C07D307/14; C07D401/12; C07F7/18; A61K; C07C; C07D; (IPC1-7): C07C275/36; A61K31/17; A61K31/18; A61K31/341; A61K31/40; A61K31/4035; A61K31/4406; A61K31/4409; A61K31/4439; A61K31/4453; A61K31/495; A61K31/496; A61K31/5355; A61K31/5375; A61P35/00; A61P43/00; C07C291/12; C07C311/29; C07C317/22; C07D207/09; C07D209/46; C07D209/48; C07D213/74; C07D213/75; C07D213/79; C07D213/81; C07D213/82; C07D295/12; C07D295/18; C07D307/14; C07D401/12; C07F7/18
Attorney, Agent or Firm:
Akaoka Mio